Valerie Weaver McCormick was startled recently to find her 9-year-old son, Preston, on the floor beside his bed.
“Oh my gosh,” she said, “I didn’t even know he could move around that much.”
While it means Preston now sleeps in a safety bed, the boy bombarded by constant seizures that have slowed his development also seems more animated, moving around his head and vocalizing more, seeming to respond to people in ways he had not before. Preston was the first child in Georgia to officially go on a clinical trial at Augusta University for marijuana-derived cannabidiol oil nearly two years ago, and preliminary evidence shows that dozens of those children are seeing some benefit.
In data presented last week at the annual meeting of the American Epilepsy Society, principal investigator Yong Park of AU found that cannabidiol oil drug Epidiolex reduced seizures by 51 percent with a 48 percent reduction in major